InvestSMART

Austco Healthcare Limited (ASX:AHC)

ALERT: Price-sensitive ASX Announcement for AHC
Current share price for AHC : $0.220 -0.085 (-27.87%)+
Announcement
Release
1 Jun 2026 9:10AM
Price at Release
$0.305
Full Release
download
Summary
Austco Healthcare Limited provided a trading update for FY26, anticipating revenue growth between $90 million and $95 million, an increase of 11% to 17% from the previous year. The expected EBITDA is set between $14.0 million and $14.6 million, maintaining a margin of about 15.5%. A significant boost in net profit after tax is expected, ranging from $9.0 million to $9.4 million, which is a substantial rise from FY25's $5.9 million. The gross margin is projected at approximately 52.8%. Growth is supported by a major contract in the US for deploying Pulse Mobile across 180 hospitals, alongside new contracts in New Zealand, Australia, Canada, and the US. These developments fuel a positive outlook for continued sales momentum and growth into FY27. The update is authorized by Austco's Board.
Key Points
  • Revenue expected in the range $90 million to $95 million for FY26, up 11% to 17% on FY25.
  • EBITDA expected between $14.0 million and $14.6 million, with a margin of approximately 15.5%.
  • Net profit after tax anticipated to be between $9.0 million and $9.4 million, up 52% to 58% from FY25.
  • Gross margin projected around 52.8%.
  • Significant US contract for Pulse Mobile deployment across 180 hospitals.
  • New contract wins in New Zealand, Australia, Canada, and the United States.
  • Company expects continued sales momentum and growth into FY27.
  • The announcement is authorized by the Board of Austco Healthcare Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.